Central Nervous System Pharmacology Practice Questions

Q: Which local anaesthetic is known to cause methemoglobinemia?

Prilocaine. ***Prilocaine*** - **Prilocaine** is metabolized into **ortho-toluidine**, which can oxidize hemoglobin to **methemoglobin**, especially at higher doses or in susceptible individuals. - **Methemoglobinemia** symptoms include **cyanosis**, **dyspnea**, and in severe cases, central nervous system depression, due to reduced oxygen-carrying capacity of blood. *Procaine* - **Procaine** is an ester-type local anesthetic. It is metabolized to **para-aminobenzoic acid (PABA)**, which can cause allergic reactions, but it is not associated with methemoglobinemia. - It has a relatively **short duration of action** and is less commonly used now compared to amide-type local anesthetics. *Etidocaine* - **Etidocaine** is an amide-type local anesthetic that is known for its **long duration of action** and high potency. - While it can cause systemic toxicity with high doses due to its cardiac and neurological effects, **methemoglobinemia** is not a characteristic side effect. *Ropivacaine* - **Ropivacaine** is an amide-type local anesthetic similar to bupivacaine, known for its **motor-sparing effect** and use in regional anesthesia. - It is associated with a lower risk of **cardiotoxicity** compared to bupivacaine but does not cause methemoglobinemia.

Q: All are symptoms of morphine withdrawal except?

Fall in BP. ***Fall in BP*** - **Hypotension (fall in BP)** is **not** typically a symptom of opioid withdrawal; rather, **hypertension** can occur due to sympathetic overdrive. - Opioid withdrawal symptoms are primarily characterized by **hyperactivity** and increased sympathetic nervous system activity. *Mydriasis* - **Mydriasis (dilated pupils)** is a classic symptom of opioid withdrawal, resulting from reduced parasympathetic tone and increased sympathetic activity. - In contrast, opioid intoxication causes **miosis (pinpoint pupils)**. *Yawning* - **Yawning** is a very common and early symptom of opioid withdrawal, often accompanied by feelings of fatigue and restlessness. - It reflects generalized **autonomic dysregulation** during withdrawal. *Lacrimation* - **Lacrimation (tearing)** is another prominent autonomic symptom of opioid withdrawal. - This, along with rhinorrhea, contributes to the **"flu-like" symptoms** experienced during withdrawal.

Q: What is the drug of choice for managing generalized tonic-clonic seizures (GTCS) during pregnancy?

Lamotrigine. ***Lamotrigine*** - **Lamotrigine** is considered **one of the preferred drugs** for managing epilepsy during pregnancy due to its relatively **low teratogenic risk** compared to older antiepileptic drugs. - Its established safety profile in pregnancy makes it a preferred option to balance seizure control and **fetal well-being**. - **Important Note:** For **GTCS specifically**, lamotrigine and levetiracetam are both considered appropriate first-line choices, with selection depending on individual patient factors and seizure control history. - Lamotrigine levels **decrease during pregnancy** and require monitoring and dose adjustments. *CBZ* - **Carbamazepine (CBZ)** is associated with an increased risk of **neural tube defects** and other congenital malformations when used during pregnancy, making it less favorable. - While effective for GTCS, its teratogenicity often leads to avoidance or careful consideration of alternatives in pregnant women. *Levetiracetam* - **Levetiracetam** is increasingly recognized as an **excellent choice for GTCS in pregnancy** with a favorable safety profile and growing evidence base. - Many recent guidelines and clinical practices favor levetiracetam as **first-line for GTCS** due to its low risk of major congenital malformations and good efficacy. - It is a **medically appropriate alternative** to lamotrigine, and in some contexts may be preferred, particularly for primary generalized epilepsy. *Valproate* - **Valproate** has the highest risk of **teratogenicity** among common antiepileptic drugs, including a significant risk of **neural tube defects**, developmental delay, autism spectrum disorder, and other anomalies. - Due to these significant risks, valproate is generally **contraindicated** in women of childbearing potential, especially during pregnancy, unless no other effective and safer alternative exists.

Q: Which of the following statements about lamotrigine is correct?

Has a half-life of approximately 24 hours.. ***Has a half-life of approximately 24 hours.*** - Lamotrigine's **half-life** is typically around **24 to 33 hours** in adults, which allows for once or twice-daily dosing. - This relatively long half-life is advantageous for maintaining **stable plasma concentrations** and improving patient adherence. *Is the first choice for absence seizures.* - **Ethosuximide** or **valproate** are generally considered first-line treatments for **absence seizures**. - Lamotrigine is not the preferred initial therapy due to its **slower titration** and occasional lack of efficacy in this seizure type. *Is not significantly metabolized in the liver.* - Lamotrigine is **significantly metabolized** in the liver, primarily through **glucuronidation** by the **UGT1A4 enzyme**. - This hepatic metabolism explains many of its **drug interactions**, particularly with other antiepileptic drugs affecting UGT enzymes. *Has decreased efficacy in treating depressive episodes.* - Lamotrigine is known for its **mood-stabilizing properties** and is effective in treating and preventing **depressive episodes**, particularly in **bipolar disorder**. - Its efficacy in depression is a key distinguishing feature, making it a valuable option for patients with comorbid mood disorders.

Q: Visual field monitoring is important before starting which of the following drugs for epilepsy treatment?

Vigabatrin. ***Vigabatrin*** - **Vigabatrin** is known to cause **irreversible concentric visual field constriction** (peripheral vision loss) due to retinal toxicity. - Regular **ophthalmological monitoring**, including **visual field testing**, is crucial before and during treatment to detect and manage this adverse effect early. *Topiramate* - Topiramate can cause **acute angle-closure glaucoma** and **myopia**, which affect vision, but regular visual field monitoring is not a primary requirement for this specific side effect. - Its main concerns often relate to cognitive side effects and kidney stones, rather than progressive visual field loss requiring baseline and ongoing field testing. *Valproic acid* - Valproic acid is not typically associated with specific visual field defects requiring routine monitoring. - Its major side effects often involve **hepatotoxicity**, **pancreatitis**, and **teratogenicity**. *Carbamazepine* - Carbamazepine's notable side effects include **aplastic anemia**, **hyponatremia**, and **Stevens-Johnson syndrome**. - While it can cause some ocular side effects like **diplopia** or **nystagmus**, it does not typically lead to the progressive and irreversible visual field constriction seen with vigabatrin, which necessitates strict monitoring.

Q: Which of the following is NOT typically produced by local anesthetics?

Dysphoria. Detailed Analysis: ***Dysphoria*** - While local anesthetics can cause a range of central nervous system effects with toxicity, **dysphoria** (a state of unease or generalized dissatisfaction with life) is not a typical or primary direct effect of their action on receptors. High doses or systemic absorption might lead to anxiety and restlessness, but dysphoria specifically is uncommon. - The primary mechanism of local anesthetics involves blocking **voltage-gated sodium channels** [1], leading to a reversible loss of sensation, not directly causing mood disturbances like dysphoria. *Euphoria* - **Euphoria** can sometimes be observed with systemic local anesthetic toxicity due to initial CNS stimulation before depression. Some individuals report a transient feeling of well-being or altered mental status with high systemic levels of certain local anesthetics. - This effect is not a direct therapeutic goal but rather an **adverse reaction** associated with systemic absorption and CNS excitation. *Analgesia* - **Analgesia** is the primary therapeutic effect of local anesthetics, achieved by blocking nerve impulse transmission. This prevents the sensation of pain from reaching the brain [1]. - They work by **blocking sodium channels** in nerve membranes [1], thereby inhibiting the initiation and propagation of action potentials [2]. *Muscle relaxation* - **Muscle relaxation** in the area of blockade is a direct consequence of the local anesthetic's action on the motor nerves supplying the muscles. - By blocking nerve conduction in **motor nerve fibers** [1], local anesthetics prevent muscle contraction, leading to temporary skeletal muscle paralysis.

Q: Which is a GABA transaminase inhibitor?

Valproate. ***Valproate*** - Valproate is known to inhibit **GABA transaminase**, an enzyme responsible for the breakdown of **gamma-aminobutyric acid (GABA)**. - By inhibiting this enzyme, valproate increases the concentration of **GABA** in the brain, enhancing its inhibitory effects and contributing to its anticonvulsant properties. *TCA* - **Tricyclic antidepressants (TCAs)** primarily work by inhibiting the reuptake of **norepinephrine** and **serotonin** in the brain. - They do not directly inhibit GABA transaminase but rather modulate monoamine neurotransmission. *Sertraline* - **Sertraline** is a **selective serotonin reuptake inhibitor (SSRI)** that works by blocking the reabsorption of **serotonin** into presynaptic neurons. - Its primary mechanism of action is focused on serotonin pathways, not on GABA metabolism. *Gabapentin* - **Gabapentin** is an anticonvulsant that is thought to exert its effects by modulating **calcium channels** and increasing **GABA synthesis**, but it is not a direct inhibitor of GABA transaminase. - Its mechanism of action is distinct from directly preventing GABA breakdown.

Q: What serious side effect may lead to the discontinuation of felbamate?

Aplastic anemia. ***Aplastic anemia*** - Felbamate is known to cause **aplastic anemia**, a severe and life-threatening condition where the **bone marrow stops producing enough new blood cells**. - Felbamate carries a **black box warning** for both aplastic anemia and **hepatotoxicity (severe liver failure)**, which are the two most serious adverse effects leading to discontinuation. - Due to this significant risk, felbamate is reserved for severe, refractory epilepsy cases, and patients require **regular monitoring** of blood counts and liver function tests. *Renal impairment* - While some medications can cause renal impairment, **felbamate is not primarily associated** with this side effect to the extent of requiring discontinuation. - Its metabolism and excretion are predominantly **hepatic (liver)**, and renal effects are less common or severe. *Gastrointestinal disorder* - Gastrointestinal side effects like nausea or vomiting are **common with many medications**, including felbamate, but are generally **mild and manageable**, rarely leading to discontinuation. - These effects are usually **dose-dependent** and can often be mitigated with supportive care. *Seizures* - Felbamate is an **antiepileptic drug (AED)**, so it is used to treat seizures, not cause them. - If a patient experiences seizures while on felbamate, it usually indicates **inadequate treatment response** or seizure exacerbation, rather than a direct side effect necessitating discontinuation for toxicity.

Q: Which of the following drugs is used for Smoking Cessation?

Bupropion. ***Bupropion*** - **Bupropion** is an antidepressant that is also approved as a smoking cessation aid. It works by inhibiting the reuptake of **dopamine** and **norepinephrine**, which can help reduce nicotine cravings and withdrawal symptoms. - It is often prescribed as a first-line pharmacotherapy for smoking cessation, with a typical treatment duration of 7-12 weeks. *Buprenorphine* - **Buprenorphine** is a partial opioid agonist primarily used to treat opioid addiction. It is not indicated for smoking cessation. - While it can help manage withdrawal symptoms from opioids, it has no direct mechanism of action that would reduce nicotine dependence or cravings. *Methadone* - **Methadone** is a full opioid agonist primarily used for the treatment of opioid use disorder (OUD) and chronic pain management. It is not used for smoking cessation. - Its mechanism involves binding to opioid receptors to prevent withdrawal symptoms and reduce cravings for other opioids. *Naltrexone* - **Naltrexone** is an opioid antagonist used primarily for the treatment of alcohol dependence and opioid use disorder. It is not indicated for smoking cessation. - It blocks the effects of opioids and reduces alcohol cravings, but does not affect nicotine pathways or dependence.

Q: Which of the following is not an ionic receptor?

mGluR. **Ionic receptors** (ionotropic receptors) are ligand-gated ion channels that open upon binding, allowing ions to flow directly through the channel. **Non-ionic receptors** (metabotropic receptors) are G-protein coupled receptors that activate intracellular signaling cascades. ***mGluR*** - **Metabotropic glutamate receptors (mGluRs)** are **G-protein coupled receptors** (GPCRs), meaning they activate intracellular signaling pathways rather than directly forming an ion channel. - Their activation leads to slower, longer-lasting changes in neuronal excitability through second messenger systems. - **This is the correct answer** as mGluRs are NOT ionic receptors. *NMDA* - **NMDA receptors** are **ionotropic glutamate receptors** that form ligand-gated ion channels permeable to calcium and sodium ions. - They are crucial for **synaptic plasticity** and learning. *Kainate* - **Kainate receptors** are also **ionotropic glutamate receptors** that are permeable to sodium and potassium ions. - They play diverse roles in synaptic transmission and neuronal excitability. *AMPA* - **AMPA receptors** are **ionotropic glutamate receptors** primarily responsible for fast excitatory synaptic transmission in the central nervous system. - They are permeable to sodium and potassium ions and mediate the majority of fast excitatory synaptic currents.

Question 1

Which local anaesthetic is known to cause methemoglobinemia?

Accepted Answer

Prilocaine

Answer

Procaine

Answer

Ropivacaine

Answer

Etidocaine

Question 2

All are symptoms of morphine withdrawal except?

Accepted Answer

Fall in BP

Answer

Yawning

Answer

Lacrimation

Answer

Mydriasis

Question 3

What is the drug of choice for managing generalized tonic-clonic seizures (GTCS) during pregnancy?

Accepted Answer

Lamotrigine

Answer

CBZ

Answer

Levetiracetam

Answer

Valproate

Question 4

Which of the following statements about lamotrigine is correct?

Accepted Answer

Has a half-life of approximately 24 hours.

Answer

Is the first choice for absence seizures.

Answer

Is not significantly metabolized in the liver.

Answer

Has decreased efficacy in treating depressive episodes.

Question 5

Visual field monitoring is important before starting which of the following drugs for epilepsy treatment?

Accepted Answer

Vigabatrin

Answer

Topiramate

Answer

Valproic acid

Answer

Carbamazepine

Question 6

Which of the following is NOT typically produced by local anesthetics?

Accepted Answer

Dysphoria

Answer

Muscle relaxation

Answer

Euphoria

Answer

Analgesia

Question 7

Which is a GABA transaminase inhibitor?

Accepted Answer

Valproate

Answer

TCA

Answer

Gabapentin

Answer

Sertraline

Question 8

What serious side effect may lead to the discontinuation of felbamate?

Accepted Answer

Aplastic anemia

Answer

Seizures

Answer

Renal impairment

Answer

Gastrointestinal disorder

Question 9

Which of the following drugs is used for Smoking Cessation?

Accepted Answer

Bupropion

Answer

Methadone

Answer

Buprenorphine

Answer

Naltrexone

Question 10

Which of the following is not an ionic receptor?

Accepted Answer

mGluR

Answer

Kainate

Answer

AMPA

Answer

NMDA

Central Nervous System Pharmacology — MCQs

Central Nervous System Pharmacology — MCQs

On this page

Practice by Chapter

Want unlimited practice?